2009
DOI: 10.1007/s10741-009-9148-8
|View full text |Cite
|
Sign up to set email alerts
|

Why, when, and how to assess pulmonary congestion in heart failure: pathophysiological, clinical, and methodological implications

Abstract: Acute heart failure syndrome (AHFS) is a major public health problem. It is defined as gradual or rapid change in heart failure (HF) signs and symptoms, which often results in an unplanned hospitalization and a need for urgent therapy. Many evidence-based pharmacologic, device, and surgical treatment for HF are available or under development. Despite these new treatments and improvement in survival, hospitalizations in HF have steadily increased over the last 30 years, and the post-discharge prognosis of patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
65
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 96 publications
(70 citation statements)
references
References 42 publications
2
65
0
3
Order By: Relevance
“…Pulmonary congestion may be semiquantified using lung ultrasound [22,25,27,[51][52][53][54][55]. In the clinical arena, lung ultrasound can therefore be employed as a bedside, easy-to-use, alternative tool for monitoring pulmonary congestion changes in heart failure patients, as they disappear or clear upon adequate medical treatment [27,[56][57][58][59][60]. More generally, any significant change in lung aeration resulting from any therapy aimed at reversing aeration loss might be detected by corresponding changes in lung ultrasound patterns [61,62].…”
Section: P-d3-s2 (Strong: Level A)mentioning
confidence: 99%
“…Pulmonary congestion may be semiquantified using lung ultrasound [22,25,27,[51][52][53][54][55]. In the clinical arena, lung ultrasound can therefore be employed as a bedside, easy-to-use, alternative tool for monitoring pulmonary congestion changes in heart failure patients, as they disappear or clear upon adequate medical treatment [27,[56][57][58][59][60]. More generally, any significant change in lung aeration resulting from any therapy aimed at reversing aeration loss might be detected by corresponding changes in lung ultrasound patterns [61,62].…”
Section: P-d3-s2 (Strong: Level A)mentioning
confidence: 99%
“…9 Lung ultrasound (US) is a novel, validated technique that has been increasingly applied to estimate lung water in patients with heart disease 10 and patients with acute respiratory failure treated in intensive care units. 11 The rationale of this technique is that, in the presence of lung congestion, the US beam is reflected by thickened interlobular septa, a phenomenon generating hyperechoic reverberation artifacts between edematous septa and the overlying pleura (i.e., US bundles at narrow basis going from the US transducer to the limit of the screen, the so-called lung comets, 12 which can be considered as a US equivalent of B lines [BL-US] detected in chest x-rays).…”
mentioning
confidence: 99%
“…2 It is now recognised that not only is fluid accumulation and retention, a mechanism for acute pulmonary oedema, but so too is fluid redistribution from the systemic circulation to the pulmonary circulation due to venoconstriction or vasoconstriction in a person who is euvolaemic. 3,4 Therapies for the treatment of acute pulmonary oedema reverse one or more of these factors, with re-absorption of pulmonary oedema both a passive and an active process. 5 Frequently, more than one risk factor is present, with iatrogenic fluid administration a major preventable factor.…”
Section: Discussionmentioning
confidence: 99%